Institute of HIV Research and Innovation Foundation, Thailand
13
6
7
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 13 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (13)
Integrating Sexual Pleasure Into Harm Reduction Services for Men Who Have Sex With Men and Transgender Persons Who Engage in Chemsex or Substance Use in Thailand
Role: lead
Comprehensive Assessment in a Longitudinal Study on Young Men Who Have Sex With Men Attracting to chemseX
Role: lead
Comprehensive Assessment in a Longitudinal Study on Young Men Who Have Sex With Men Attracting to chemseX-2
Role: lead
Behavioral and Psychosocial Characteristics of Clients Accessing Services at IHRI
Role: lead
Anal HSIL Screening Algorithm
Role: lead
Pre-implementation Study to Develop Trans-tailored Services for Transgender Persons in Relation to chemsEX
Role: lead
The South-East Asian Transgender Health Cohort
Role: lead
KP-Led Same Day HCV Test and Treat Study
Role: lead
LA PrEP Impact and Cost-effectiveness (TEAMS)
Role: lead
Developing mHealth to Promote PrEP Use Among Thai Young Vulnerable Adolescents and Emerging Adults
Role: collaborator
Developing mHealth to Promote PrEP Use Among Thai Young Men Who Have Sex With Men
Role: collaborator
Thailand HIV and Stigma Reduction Study
Role: collaborator
Undetectable = Untransmissible in Thailand (888/64)
Role: lead
All 13 trials loaded